SUBJECTS : Breast Cancer | | Prevention | Diagnosis | Treatment | Breast Cancer Surger
Breast: 2023, vol: 72, issue:
- 1)- Thomas Decker, Kerstin Lüdtke-Heckenkamp, Luidmila Melnichuk, Nader Hirmas, Kristina Lübbe, Mark-Oliver Zahn, Marcus Schmidt, Carsten Denkert, Ralf Lorenz, Volkmar Müller, Dirk-Michael Zahm, Christoph Mundhenke, Stefan Bauer, Marc Thill, Peter Seropian, Natalie Filmann, Sibylle Loibl. Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA). Breast (Edinburgh, Scotland). 2023, 72: 103575
Cited : 5Read More - 2)- Leonor Vasconcelos de Matos, Simona Volovat, Marcio Debiasi, Fatima Cardoso. Unfolding the role of the PI3K/AKT/MTOR pathway in male breast cancer: A pragmatic appraisal. Breast (Edinburgh, Scotland). 2023, 72: 103576Cited : 2Read More
- 3)- Marcelo Antonini, André Mattar, Fernanda Grace Bauk Richter, Gabriel Duque Pannain, Marina Diógenes Teixeira, Andressa Gonçalves Amorim, Odair Ferraro, Reginaldo Coelho Guedes Lopes, Luiz Henrique Gebrim, Juliana Monte Real. Real-world evidence of neoadjuvant chemotherapy for breast cancer treatment in a Brazilian multicenter cohort: Correlation of pathological complete response with overall survival. Breast (Edinburgh, Scotland). 2023, 72: 103577Cited : 1Read More
- 4)- Tanwiwat Jaikuna, Eliana Vasquez Osorio, David Azria, Jenny Chang-Claude, Maria Carmen De Santis, Sara Gutiérrez-Enríquez, Marcel van Herk, Peter Hoskin, Maarten Lambrecht, Zoe Lingard, Petra Seibold, Alejandro Seoane, Elena Sperk, R Paul Symonds, Christopher J Talbot, Tiziana Rancati, Tim Rattay, Victoria Reyes, Barry S Rosenstein, Dirk de Ruysscher, Ana Vega, Liv Veldeman, Adam Webb, Catharine M L West, Marianne C Aznar. Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy. Breast (Edinburgh, Scotland). 2023, 72: 103578Cited : 2Read More
- 5)- Sivaporn Pondeenana, Chao Saenghirunvattana, Patcharin Intarakhao, Sorasit Inchan, Panuwat Chuemor, Atthakorn Jarusriwanna. Additional intraoperative subpectoral plane block vs conventional pain control: A comparison of shoulder movement in patients with mastectomy. Breast (Edinburgh, Scotland). 2023, 72: 103579Cited : 1Read More
- 6)- Guy Jerusalem, Aleix Prat, Roberto Salgado, Mattea Reinisch, Cristina Saura, Manuel Ruiz-Borrego, Petros Nikolinakos, Felipe Ades, Jeiry Filian, Ning Huang, Antonella Mazzei-Abba, Sara M Tolaney. Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8. Breast (Edinburgh, Scotland). 2023, 72: 103580Cited : 3Read More
- 7)- Maiyue He, Jiaxuan Liu, Zijing Wang, Fei Ma, Jiayu Wang, Pin Zhang, Qing Li, Peng Yuan, Yang Luo, Ying Fan, Hongnan Mo, Bo Lan, Qiao Li, Binghe Xu. Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial. Breast (Edinburgh, Scotland). 2023, 72: 103581Cited : 0Read More
- 8)- E R Copson, J E Abraham, J P Braybrooke, D Cameron, S A McIntosh, C O Michie, A F C Okines, C Palmieri, F Raja, R Roylance, S Spensley, . Expert UK consensus on the definition of high risk of recurrence in HER2-negative early breast cancer: A modified Delphi panel. Breast (Edinburgh, Scotland). 2023, 72: 103582Cited : 1Read More
- 9)- Massimo Di Maio, Claudia Bighin, Francesco Schettini, Tommaso Ruelle, Laura Marandino, Alessandra Fabi, Carmine De Angelis, Mario Giuliano, Pietro De Placido, Michelino De Laurentiis, Ferdinando Riccardi, Caterina Picotto, Fabio Puglisi, Lucia Del Mastro, Grazia Arpino, . Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study. Breast (Edinburgh, Scotland). 2023, 72: 103583Cited : 2Read More
- 10)- Orit Kaidar-Person, Birgitte Vrou Offersen, Trine Tramm, Peer Christiansen, Tine Engberg Damsgaard, Ashutosh Kothari, Philip Poortmans. The King is in the altogether: Radiation therapy after oncoplastic breast surgery. Breast (Edinburgh, Scotland). 2023, 72: 103584Cited : 2Read More
- 11)- Anbok Lee, Taewoo Kang, Su Hwan Kang, Woo-Chan Park, Woosung Lim, Myung-Chul Chang, Hyun Yul Kim, Jeong-Yoon Song, Jihyoun Lee, Kyung Do Byun, Hyun-Ah Kim, Gil Soo Son, Ju-Yeon Kim, Se Jeong Oh, Min Sung Chung, Young Jin Choi, Hyuk-Jai Shin, Jong Min Baek, Youngbum Yoo, Eunhae Um, Jin Hyuk Choi, Beom Seok Kwak, Min Ho Park, Suok Hyun Lee, Cheol Seung Kim, Ilkyun Lee, Je-Ryong Kim, Han Shin Lee, Cheol Wan Lim. An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer. Breast (Edinburgh, Scotland). 2023, 72: 103585Cited : 1Read More
- 12)- Jan Paredes Mogica, Haiming Tang, Yuanxin Liang, Minghao Zhong, Pei Hui, Malini Harigopal, Uma Krishnamurti, Neal A Fischbach, Haiying Zhan. Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literature. Breast (Edinburgh, Scotland). 2023, 72: 103586Cited : 0Read More
- 13)- M E Brennan, K Bell, G Hamid, J Gilchrist, J Gillingham. Consumer experiences of shame in clinical encounters for breast cancer treatment. "Who do you think you are- Angelina Jolie?". Breast (Edinburgh, Scotland). 2023, 72: 103587Cited : 2Read More
- 14)- Eric C Barat, Marianne L E Arrii, Annaelle Soubieux-Bourbon, Mikaël Daouphars, Rémi Varin, Patrick R Tilleul. Cost effectiveness of using trastuzumab biosimilars compared to trastuzumab original drugs to treat breast cancer in a hospital setting. Breast (Edinburgh, Scotland). 2023, 72: 103588Cited : 0Read More
- 15)- Qian Zhao, Fan Yang, Huai-Liang Wu, Miao Mo, Yun-Xiao Ling, Guang-Yu Liu. Contralateral axillary lymph node metastasis in breast cancer: An oligometastatic-like disease. Breast (Edinburgh, Scotland). 2023, 72: 103589Cited : 1Read More
- 16)- Tjaša Oblak, Petra Škerl, Benjamin J Narang, Rok Blagus, Mateja Krajc, Srdjan Novaković, Janez Žgajnar. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence. Breast (Edinburgh, Scotland). 2023, 72: 103590Cited : 0Read More
- 17)- Kai Cc Johnson, Michael Grimm, Jasmine Sukumar, Patrick M Schnell, Ko Un Park, Daniel G Stover, Sachin R Jhawar, Margaret Gatti-Mays, Robert Wesolowski, Nicole Williams, Sagar Sardesai, Ashley Pariser, Preeti Sudheendra, Gary Tozbikian, Bhuvaneswari Ramaswamy, Dureti Doto, Mathew A Cherian. Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls. Breast (Edinburgh, Scotland). 2023, 72: 103591Cited : 1Read More
- 18)- Benigno Acea-Nebril, Alejandra García-Novoa, Alberto Bouzón Alejandro, Carlota Díaz Carballada, Carmen Conde Iglesias. Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients. Breast (Edinburgh, Scotland). 2023, 72: 103592Cited : 0Read More
- 19)- Lucien E M Duijm, Luc J A Strobbe, Vivian van Breest Smallenburg, Clemence L Op de Coul-Froger, Wikke Setz-Pels, Willem Vreuls, Hermen C van Beek, Rob M G van Bommel, Adri C Voogd. Trends in the pre-operative diagnosis and surgical management of axillary lymph node metastases in women with screen-detected breast cancer. Breast (Edinburgh, Scotland). 2023, 72: 103593Cited : 0Read More
- 20)- Nalee Kim, Ji-Yeon Kim, Won Park, Won Kyung Cho, Tae Gyu Kim, Young-Hyuck Im, Jin Seok Ahn, Jeong Eon Lee, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Sei Kyung Lee, Jai-Min Ryu, Yeon Hee Park, Haeyoung Kim. Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer. Breast (Edinburgh, Scotland). 2023, 72: 103594Cited : 0Read More
- 21)- Na Li, Weiyun Gong, Yuanzhong Xie, Lei Sheng. Correlation between the CEM imaging characteristics and different molecular subtypes of breast cancer. Breast (Edinburgh, Scotland). 2023, 72: 103595Cited : 4Read More
- 22)- Manita Chaum, Sara Grossi, Jiaxi Chen, Vivian Hu, Edward Ray, Armando Giuliano, Shikha Bose. Masculinizing hormone therapy effect on breast tissue: Changes in estrogen and androgen receptors in transgender female-to-male mastectomies. Breast (Edinburgh, Scotland). 2023, 72: 103596Cited : 1Read More
- 23)- Binliang Liu, Ning Xie, Can Tian, Ronghua Feng, Zhe-Yu Hu, Jing Li, Liping Liu, Huawu Xiao, Xiaohong Yang, Mengsi Zeng, Hui Wu, Jun Lu, Jianxiang Gao, Xuming Hu, Min Cao, Zhengrong Shui, Yu Tang, Tao Wu, Quchang Ouyang. Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody. Breast (Edinburgh, Scotland). 2023, 72: 103597Cited : 1Read More
- 24)- Fadila Kouhen. Omitting radiotherapy in elderly breast cancer patients: Valid strategy or illusory hope? Breast (Edinburgh, Scotland). 2023, 72: 103598Cited : 0Read More
